Selective dose escalation of chemoradiotherapy for esophageal cancer: Role of treatment intensification

被引:17
作者
Seung, SK
Smith, JW
Molendyk, J
Bader, SB
Phillips, M
Regan, J
Louie, J
Soo, E
Seligman, M
Ruzich, J
Skokan, L
Ross, HJ
机构
[1] Oregon Clin, Portland, OR 97213 USA
[2] NW Canc Specialists, Portland, OR USA
[3] Oregon Hematol Oncol Associates, Portland, OR USA
[4] Providence Portland Med Ctr, Portland, OR USA
[5] Earle A Chiles Res Inst, Portland, OR USA
关键词
D O I
10.1053/j.seminoncol.2004.12.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:13 / 19
页数:7
相关论文
共 33 条
[11]   PREOPERATIVE CHEMORADIATION FOLLOWED BY TRANSHIATAL ESOPHAGECTOMY FOR CARCINOMA OF THE ESOPHAGUS - FINAL REPORT [J].
FORASTIERE, AA ;
ORRINGER, MB ;
PEREZTAMAYO, C ;
URBA, SG ;
ZAHURAK, M .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) :1118-1123
[12]   A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy [J].
Freifeld, A ;
Marchigiani, D ;
Walsh, T ;
Chanock, S ;
Lewis, L ;
Hiemenz, J ;
Hiemenz, S ;
Hicks, JE ;
Gill, V ;
Steinberg, SM ;
Pizzo, PP .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (05) :305-311
[13]   Cancer statistics, 2001 [J].
Greenlee, RT ;
Hill-Harmon, MB ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) :15-36
[14]   COMBINED CHEMOTHERAPY AND RADIOTHERAPY COMPARED WITH RADIOTHERAPY ALONE IN PATIENTS WITH CANCER OF THE ESOPHAGUS [J].
HERSKOVIC, A ;
MARTZ, K ;
ALSARRAF, M ;
LEICHMAN, L ;
BRINDLE, J ;
VAITKEVICIUS, V ;
COOPER, J ;
BYHARDT, R ;
DAVIS, L ;
EMAMI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (24) :1593-1598
[15]  
HESKETH PJ, 1989, CANCER, V64, P526, DOI 10.1002/1097-0142(19890715)64:2<526::AID-CNCR2820640228>3.0.CO
[16]  
2-B
[17]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[18]   Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: Report of a randomized comparative trial [J].
Komaki, R ;
Lee, JS ;
Milas, L ;
Lee, HK ;
Fossella, FV ;
Herbst, RS ;
Allen, PK ;
Liao, ZX ;
Stevens, CW ;
Lu, C ;
Zinner, RG ;
Papadimitrakopoulou, VA ;
Kies, MS ;
Blumenschein, GR ;
Pisters, KM ;
Glisson, BS ;
Kurie, J ;
Kaplan, B ;
Garza, VP ;
Mooring, D ;
Tucker, SL ;
Cox, JD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (05) :1369-1377
[19]   Pharmacokinetics of amifostine and its metabolites in patients [J].
Korst, AEC ;
Eeltink, CM ;
Vermorken, JB ;
vanderVijgh, WJF .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (09) :1425-1429
[20]  
Koukourakis MI, 2003, CLIN CANCER RES, V9, P3288